GOLD in Practice: Chronic Obstructive Pulmonary Disease Treatment and Management in the Primary Care Setting

References

• Viegi G, Maio S, Fasola S, Baldacci S. Global burden of chronic respiratory diseases. J Aerosol Med Pulm Drug Deliv. 2020;33(4):171–177. doi:10.1089/jamp.2019.1576
   PubMed Web of Science ®Google Scholar
• Murphy SL, Xu J, Kochanek KD, Arias E. Mortality in the United States, 2017. NCHS Data Brief. 2018;(328):1–8.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. COPD death rates in the United States. Available from: https://www.cdc.gov/copd/data.html. Accessed October 26, 2020.
   Google Scholar
• Vorrink SN, Kort HS, Troosters T, Lammers JW. Level of daily physical activity in individuals with COPD compared with healthy controls. Respir Res. 2011;12(1):33. doi:10.1186/1465-9921-12-33
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for prevention, diagnosis, and management of chronic obstructive pulmonary disease; 2020. Available from: https://goldcopd.org. Accessed October 26, 2020.
   Google Scholar
• Ford ES, Murphy LB, Khavjou O, Giles WH, Holt JB, Croft JB. Total and state-specific medical and absenteeism costs of COPD among adults aged ≥18 years in the United States for 2010 and projections through 2020. Chest. 2015;147(1):31–45. doi:10.1378/chest.14-0972
   PubMed Web of Science ®Google Scholar
• Bartels W, Adamson S, Leung L, Sin DD, van Eeden SF. Emergency department management of acute exacerbations of chronic obstructive pulmonary disease: factors predicting readmission. Int J Chron Obstruct Pulmon Dis. 2018;13:1647–1654. doi:10.2147/COPD.S163250
   PubMed Web of Science ®Google Scholar
• Csikesz NG, Gartman EJ. New developments in the assessment of COPD: early diagnosis is key. Int J Chronic Obstr Pulm Dis. 2014;9:277–286. doi:10.2147/COPD.S46198
   PubMed Web of Science ®Google Scholar
• Soriano JB, Polverino F, Cosio BG. What is early COPD and why is it important? Eur Respir J. 2018;52(6). doi:10.1183/13993003.01448-2018
   Web of Science ®Google Scholar
• Yawn BB, Thomashaw B, Mannino DM, et al. The 2017 update to the COPD Foundation COPD Pocket Consultant Guide. Chronic Obstr Pulm Dis. 2017;4(3):177–185. doi:10.15326/jcopdf.4.3.2017.0136
   PubMedGoogle Scholar
• Rodríguez-Roisin R. The airway pathophysiology of COPD: implications for treatment. COPD. 2005;2(2):253–262. doi:10.1081/COPD-57598
   PubMedGoogle Scholar
• Doherty DE. The pathophysiology of airway dysfunction. Am J Med. 2004;117(Suppl12A):11–23. doi:10.1016/j.amjmed.2004.10.017
   Web of Science ®Google Scholar
• Stockley RA, Mannino D, Barnes PJ. Burden and pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2009;6(6):524–526. doi:10.1513/pats.200904-016DS
   PubMedGoogle Scholar
• Singh D, Kolsum U, Brightling CE, Locantore N, Agusti A, Tal-Singer R. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J. 2014;44(6):1697–1700. doi:10.1183/09031936.00162414
   PubMed Web of Science ®Google Scholar
• Marchetti N, Kaplan A. Dyspnea and hyperinflation in chronic obstructive pulmonary disease: impact on physical activity. J Fam Pract. 2018;67(2):S3–S10. doi:10.3949/ccjm.85.s1.02
   PubMed Web of Science ®Google Scholar
• Chowienczyk S, Javadzadeh S, Booth S, Farquhar M. Association of descriptors of breathlessness with diagnosis and self-reported severity of breathlessness in patients with advanced chronic obstructive pulmonary disease or cancer. J Pain Symptom Manage. 2016;52(2):259–264. doi:10.1016/j.jpainsymman.2016.01.014
   PubMed Web of Science ®Google Scholar
• Jagana R, Bartter T, Joshi M. Delay in diagnosis of chronic obstructive pulmonary disease: reasons and solutions. Curr Opin Pulm Med. 2015;21(2):121–126. doi:10.1097/MCP.0000000000000133
   PubMed Web of Science ®Google Scholar
• Decramer M, Miravitlles M, Price D, et al. New horizons in early stage COPD–improving knowledge, detection and treatment. Respir Med. 2011;105(11):1576–1587. doi:10.1016/j.rmed.2010.12.015
   PubMed Web of Science ®Google Scholar
• Chapman KR, Tashkin DP, Pye DJ. Gender bias in the diagnosis of COPD. Chest. 2001;119(6):1691–1695. doi:10.1378/chest.119.6.1691
   PubMed Web of Science ®Google Scholar
• Ntritsos G, Franek J, Belbasis L, et al. Gender-specific estimates of COPD prevalence: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2018;13:1507–1514. doi:10.2147/COPD.S146390
   PubMed Web of Science ®Google Scholar
• Huang W-C, Wu M-F, Chen H-C, Hsu J-Y. Features of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional study. NPJ Prim Care Respir Med. 2015;25:15063. doi:10.1038/npjpcrm.2015.63
   PubMed Web of Science ®Google Scholar
• Holt S, Sheahan D, Helm C, Tofield C, Corin A, Kocks JWH. Little agreement in GOLD category using CAT and mMRC in 450 primary care COPD patients in New Zealand. NPJ Prim Care Respir Med. 2014;24(1):14025. doi:10.1038/npjpcrm.2014.25
   PubMedGoogle Scholar
• Postma DS, Bush A, van den Berge M. Risk factors and early origins of chronic obstructive pulmonary disease. Lancet. 2015;385(9971):899–909. doi:10.1016/S0140-6736(14)60446-3
   PubMed Web of Science ®Google Scholar
• Chilvers ER, Lomas DA. Diagnosing COPD in non-smokers: splitting not lumping. Thorax. 2010;65(6):465–466. doi:10.1136/thx.2009.128421
   PubMed Web of Science ®Google Scholar
• Busch R, Hobbs B, Zhou J, et al. Genetic association and risk scores in a chronic obstructive pulmonary disease meta-analysis of 16,707 subjects. Am J Respir Cell Mol Biol. 2017;57(1):35–46. doi:10.1165/rcmb.2016-0331OC
   PubMed Web of Science ®Google Scholar
• Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–773. doi:10.1016/S0140-6736(07)61380-4
   PubMed Web of Science ®Google Scholar
• Han MK, Kim MG, Mardon R, et al. Spirometry utilization for COPD: how do we measure up? Chest. 2007;132(2):403–409. doi:10.1378/chest.06-2846
   PubMed Web of Science ®Google Scholar
• Joo MJ, Sharp LK, Au DH, Lee TA, Fitzgibbon ML. Use of spirometry in the diagnosis of COPD: a qualitative study in primary care. COPD. 2013;10(4):444–449. doi:10.3109/15412555.2013.766683
   PubMedGoogle Scholar
• Saad N, Sedeno M, Metz K, Bourbeau J. Early COPD diagnosis in family medicine practice: how to implement spirometry? Int J Family Med. 2014;2014:962901. doi:10.1155/2014/962901
   PubMedGoogle Scholar
• Ruppel GL, Carlin BW, Hart M, Doherty DE. Office spirometry in primary care for the diagnosis and management of COPD: National Lung Health Education Program update. Respir Care. 2018;63(2):242–252. doi:10.4187/respcare.05710
   PubMed Web of Science ®Google Scholar
• Yawn BP, Enright PL, Lemanske RF Jr, et al. Spirometry can be done in family physicians’ offices and alters clinical decisions in management of asthma and COPD. Chest. 2007;132(4):1162–1168. doi:10.1378/chest.06-2722
   PubMed Web of Science ®Google Scholar
• Ernst P, Saad N, Suissa S. Inhaled corticosteroids in COPD: the clinical evidence. Eur Respir J. 2015;45(2):525–537. doi:10.1183/09031936.00128914
   PubMed Web of Science ®Google Scholar
• Price D, West D, Brusselle G, et al. Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns. Int J Chron Obstruct Pulmon Dis. 2014;9:889–904. doi:10.2147/COPD.S62750
   PubMed Web of Science ®Google Scholar
• Rossi A, van der Molen T, del Olmo R, et al. INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD. Eur Respir J. 2014;44(6):1548–1556. doi:10.1183/09031936.00126814
   PubMed Web of Science ®Google Scholar
• Magnussen H, Disse B, Rodriguez-Roisin R, et al. WISDOM investigators. Withdrawal of inhaled glucocorticoids and exacerbations of COPD. N Engl J Med. 2014;371(14):1285–1294. doi:10.1056/NEJMoa1407154
   PubMed Web of Science ®Google Scholar
• Chapman KR, Hurst JR, Frent SM, et al. Long-term triple therapy de-escalation to indacaterol/glycopyrronium in patients with chronic obstructive pulmonary disease (SUNSET): a randomized, double-blind, triple-dummy clinical trial. Am J Respir Crit Care Med. 2018;198(3):329–339. doi:10.1164/rccm.201803-0405OC
   PubMed Web of Science ®Google Scholar
• Safka KA, McIvor RA. Non-pharmacological management of chronic obstructive pulmonary disease. Ulster Med J. 2015;84(1):13–21.
   PubMedGoogle Scholar
• COPD Foundation. Available from: https://www.copdfoundation.org/Learn-More/Educational-Materials-Resources/Downloads.aspx#MyCOPDActionPlan. Accessed October 26, 2020.
   Google Scholar
• Hanania NA, Braman S, Adams SG, et al. The role of inhalation delivery devices in COPD: perspectives of patients and health care providers. Chronic Obstr Pulm Dis. 2018;5(2):111–123. doi:10.15326/jcopdf.5.2.2017.0168
   PubMed Web of Science ®Google Scholar
• Morris JF, Temple W. Spirometric “lung age” estimation for motivating smoking cessation. Prev Med. 1985;14(5):655–662. doi:10.1016/0091-7435(85)90085-4
   PubMed Web of Science ®Google Scholar
• Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J. 1977;1(6077):1645–1648. doi:10.1136/bmj.1.6077.1645
   PubMed Web of Science ®Google Scholar
• Doherty DE. A review of the role of FEV1 in the COPD paradigm. COPD. 2008;5(5):310–318. doi:10.1080/15412550802363386
   PubMedGoogle Scholar
• Fletcher CM. Standardized questionnaire on respiratory symptoms: a statement prepared and approved by the MRC committee on the aetiology of chronic bronchitis (MRC breathlessness score). BMJ. 1960;2:1665.
   PubMedGoogle Scholar
• Jones PW. Health status and the spiral of decline. COPD. 2009;6(1):59–63. doi:10.1080/15412550802587943
   PubMedGoogle Scholar
• COPD Foundation. Breathing Exercises and Techniques. Available from: https://www.copdfoundation.org/Learn-More/I-am-a-Person-with-COPD/Breathing-Techniques.aspx. Accessed October 26, 2020.
   Google Scholar